Innovation Award 2026 decerned to Elita Montanari & EVis Bioscience

Innovation Award 2026 – Elita Montanari & EVis Bioscience | From extracellular vesicle biology to technologies that could transform RNA delivery.

At Targeting Extracellular Vesicles 2026 in Porto, we are pleased to recognize Prof. Elita Montanari, Co-founder and CTO of EVis Bioscience AG, Switzerland, with the Innovation Award.

EVis Bioscience is developing hybrid extracellular vesicle–lipid technologies designed to improve the loading and delivery of therapeutic nucleic acids.

The approach combines the biological properties of extracellular vesicles with engineered lipid-based delivery systems, addressing important challenges in non-viral RNA delivery.

This award recognizes an important bridge between academic discovery, technological innovation and the development of future therapeutic platforms.

Congratulations to Prof. Montanari and the EVis Bioscience team for helping advance the translational possibilities of extracellular vesicle science.